Intraperitoneal injection of squalene-treated cell wall skeleton of Nocardia rubra (N-CWS) caused increase in number of peritoneal exudate cells (PEC). Adherent macrophages obtained from N-CWS-treated PEC suppressed growth of methylcholanthrene-induced fibrosarcoma (Meth-A), when injected intradermally with the tumor cells into BALB/c mice. The macrophages showed strong cytotoxicity against Meth-A cells in vitro.
When treated with 10 pg/ml of N-CWS in vitro, proteose peptone-induced macrophages acquired tumoricidal property but resident macrophages showed no cytotoxicity after the treatment.
In the supernatant of spleen cells cultured for 72 hours in the presence of N-CWS (10 pg/ml), the presence of (a) factor(s) with macrophage activating effect was observed. This factor, shown to be identical to macrophage activating factor (MAF) in molecular weight, showed synergy with N-CWS in potentiating macrophage cytotoxicity against tumor cells. Cell Line Meth-A is 3-methylcholanthrene-induced fibrosarcoma and passed serially in BALB/c mice as ascites. The cells were harvested from the ascites 6 or 7 days after the inoculation of the host animals, suspended and washed in HANKS' balanced salts solution (HBSS) by low speed centrifugation, and finally suspended in RPMI 1640 medium with 10% fetal calf serum (FCS). When used in Winn test, cells were suspended in phosphate buffered saline without Ca2+ (PBS (-)).
Peritoneal Exudate Cells Peritoneal exudate cells (PEC) were harvested by lavage with HBSS containing 10 u/ml of heparin, washed by low speed centrifugation and suspended in EAGLE'S minimum essential medium (E-MEM) without FCS. For Winn test, PEC were suspended in PBS (-).
Winn Test Expt 1. PEC were harvested after intraperitoneal injection of 100 pg of N-CWS at day-4, -8 and -12, pooled, washed and suspended in PBS (-) at a cell density of 4 x 107/ml. Meth-A cells (8 x 105/ nil) suspended in PBS (-) were mixed with the same volume of PEC suspension and 50 / l of the mixture was inoculated intradermally into the flank of normal mice. Two weeks later, tumor taken was checked grossly.
Expt 2. PEC (2 x 107) were harvested from mice 4 days after intraperitoneal injection of 100 pg N-CWS, pooled, washed with PBS (-) and suspended in 10 ml of E-MEM with 10 % FCS, and cultured in plastic dishes at 37°C in 5 % CO2 and moist air. After 2-hour incubation, adherent cells, scraped with a rubber policeman, were suspended in PBS (-) at a cell density of 4 x 107 viable cells/m] and mixed with the same volume of tumor cells (8 x 105 Meth-A cells/ml). The mixture was injected intradermally and tumor taken was checked 14 days after the inoculation.
Induction of Cytotoxic Macrophage In Vivo PEC was harvested by lavage with HBSS with heparin (10 u/ml) after injection of 100 jig N-CWS 4 and 6 days before the experiment. Cells were washed, suspended at an appropriate cell density and 200 Id of the cell suspension was plated into each well of a microtitration plate (Nunc, Denmark). Nonadherent cells were removed by washing with E-MEM 3 hours after initial plating. This procedure provided uniform monolayer of macrophages (> 95 %) identified with Giemsa staining and phagocytosis of latex beads. Macrophages were suspended in RPMI 1640 with 10% FCS and 5 x 10-5 M 2-mercaptoethanol (2-ME) and used for cytotoxicity assay.
Preparation of Lymphokines with Macrophage Activating Effect Spleens were aseptically removed from normal BALB/c mice and minced by gently teasing each spleen between frosted ends of microscope slides in RPMI 1640 with 10%, FCS. Cellular debris was removed by passing through nylon mesh and red cells were removed by treatment with red cell lysing buffer comprised 8.3 mg/ml NHCl4" 1 mg/ml KHCO3 and 3.7 mg/ml EDTA • 3Na, for 3 minutes at 4°C. The collected cells were washed and suspended in RPMI 1640 with 10% FCS and 5 x 10-5 M 2-ME at a cell density of 5 x 10°/ml. Solution of N-CWS in physiological saline (10 pg/ml) was added to the cell suspension (1 ml) and the mixture was plated into microtitration plates. After 72-hour incubation at 37°C, N-CWS was filtered off with a Millipore filter and the resultant supernatant was used for macrophage activation. of freshly prepared Sephadex were usually made for each run. The gel slurry (328 ml) was poured into a 26-mm diameter-glass column (Pharmacia, C 26/70). Height of the gel bed after setting was approximately 62 cm. The eluting fluid was 0.15 M NaCl containing 50 jig/ml of cytochrome C. In total 500 ml of eluting fluid was run through the column before sample application. Forty ml of spleen cell culture supernatant was lyophilized, reconstituted with 4 ml of RPMI 1640, and passed through the Millipore filter in order to remove undissolved residue. An aliquot was retained for bioassay. Elution rate was approximately 25 ml/hour, and fraction volume was 3.3 ml. Fractions were stored at -80°C until assay .
Induction of Cytotoxic Macrophages In Vitro
One ml of 10% Proteose peptone solution was injected intraperitoneally into BALB/c mice. Four days after the injection, PEC were harvested in E-MEM and plated in microtitration plates at a density of 2 x 106/well for 3 hours. PEC were washed to remove nonadherent cells with E-MEM and 100 µl of RPMI 1640 with 10% FCS was added. At this time, greater than 95% were macrophages as identified with Giemsa staining and phagocytosis of latex beads. The adherent cells were incubated for 24 hours in the presence of supernatant of splenocyte culture and/or N-CWS solution, washed with RPMI 1640 and added with 100,ul of RPMI 1640 with 10% FCS and 5 x 10-6 M 2-ME.
Macrophage-mediated Cytotoxicity Target cells (3 x 106/3 ml RPMI 1640) in the exponential growth phase were labeled with 2 ttCi [3H]-uridine (specific activity, 23 Ci/mmol), washed with RPMI 1640 and resuspended in RPMI 1640 with 10% FCS and 5 x 10-5 M 2-ME at a cell density of I x 106/ml. Radiolabeled target cells (100 Miter) were plated into each well containing activated macrophages and incubated at 37°C for 24 hours. At the end of incubation period, target cells were harvested on the glass filter paper with Titerteck Cell Harvester (Flow Laboratories, U.S.A.), dried and residual radioactivity was counted by a liquid scintillation counter.
Cytotoxicity (%) was calculated as follows: Table 3 , N-CWS at a concentration of 10 ,rig/ml showed significant enhancement of cytotoxicity of peritonea] exudate macrophages. However, when the resident macrophages were used as effector cells, no significant cytolytic activity was seen at any concentration of N-CWS.
To exclude the effect of contaminating T-lymphocytes and ascertain the reproducibility, nu/nu mice were employed. Macrophage induced from BALB/c nu/nu mice could also be activated to become tumoricidal at concentration of 20 and 50 ,«g/ml of N-CWS. In contrast to the cytotoxicity with normal mice, at 10 ug/ml, only a trend to an augmented cytolytic activity over placebo was shown (Table   4) .
Thus it was shown that peritoneal exudate macrophages could be rendered tumoricidal following their direct interaction with N-CWS in the culture medium. But, we could not exclude that the activa- Table 3 . Effect of N-CWS on cytotoxicity of resident and exudate macrophagesa). When 10 ,ug/ml of N-CWS was added to the macrophage culture in combination with culture supernatant of N-CWS-treated splenocyte, synergistic enhancement effect was observed (Fig. 1) . Even low concentration of the supernatant (2.5 °o v/v) was sufficient to achieve full activation of macrophage cytotoxicity in the presence of 10 ,pg/ml of N-CWS.
Sephadex G-75 Chromatography of Macrophage Activating Factor
To characterize the macrophage activating factor produced by the N-CWS-treated spleen cells, we VOL. XXXVII NO. 3 THE JOURNAL OF ANTIBIOTICS Mean±S.E. of triplicate cultures was plotted.
examined its molecular weight in Sephadex column chromatography according to the procedure mentioned in the Materials and Methods.
Macrophage activating activity of the supernatant was obtained at a position corresponding to a molecular weight of 55,000 daltons, which was confirmed in two independent experiments (Fig. 2) . Arrows indicate protein markers used to calibrate column.
No. of fraction tube
The MAF prepared by Con A stimulated splenocytes was also eluted in a fraction of the same molecular weight (data not shown). Thus the macrophage activating factor produced by the N-CWS-treated splenocytes seems similar to so-called MAF produced by lectin-stimulated splenocytes.
Discussion
In the present study, we examined in vitro activation of tumor cell cytotoxicity of macrophages to undertake and evaluation of the immunotherapeutic efficacy of N-CWS.
After intraperitoneal injection of N-CWS in BALB/c mice, PEC yield increased and the macrophages showed significant tumoricidal activity. This finding is in agreement with the experimental results of other investigators' 1-21), who have shown that the in situ administration of N-CWS can activate macrophages for tumor cell killing. When these macrophages were mixed with Meth-A cells and inoculated subcutaneously into normal mice, complete growth suppression of tumor was observed in majority of mice. A similar therapeutic effect has been reported by OGURA et al. 20) , using the Winn type transfer test in rats. YAMASHITA et al. 23 ) has shown that intraperitoneal injection of macrophages activated with N-CWS produced significant eradication of Lewis lung carcinoma metastasis. We interpret these results to indicate that the main therapeutic efficacy of N-CWS treatment is a potentiation of macrophage tumoricidal activity.
In this report, we also intended to determine how N-CWS augmented the tumoricidal activity of macrophages. At first, as shown in Tables 3 and 4 , we showed murine macrophages could respond to direct stimulation by N-CWS to become tumoricidal in vitro. These results are consistent with the data of SONE et al. 21) , which show that alveolar macrophage lavage from lung of F344 rats are rendered tumoricidal following their direct interaction with N-CWS. However, such effectiveness was recognized only in peritoneal exudate macrophages and not in resident macrophages.
Macrophages were rendered tumor cell cytotoxic by MAF prepared by incubation of spleen cells 
